Patients in advanced tumour stage with CRP/albumin ratio cut-off ≥ 0.047 were found to run a greater risk of mortality compared with those with a low CRP/albumin ratio (cut-off < 0.047)106. The gene discussed is ALB; the disease is neoplasm.